ITGAX and neoplasm: Then, cross-presentation of OVA model tumor antigens in vivo were quantitatively investigated by flow cytometry using H-2Kb-SIINFEKL+ in CD11c+ cell populations in lymph node as evaluation indicators (Figure 3B).